Works matching IS 11781653 AND DT 2015 AND VI 8 AND IP 4


Results: 8
    1
    2
    3
    4
    5
    6
    7
    8

    Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF

    Published in:
    Patient, 2015, v. 8, n. 4, p. 359, doi. 10.1007/s40271-015-0129-9
    By:
    • Mills, Anthony;
    • Garner, Will;
    • Pozniak, Anton;
    • Berenguer, Juan;
    • Speck, Rebecca;
    • Bender, Randall;
    • Nguyen, Thai
    Publication type:
    Article